To evaluate AMH level changes in patients with endometrioma before and after Dienogest therapy and to compare it with patients undergoing laparoscopic endometriotic cystectomy.
Not Applicable
- Conditions
- Health Condition 1: N801- Endometriosis of ovary
- Registration Number
- CTRI/2019/04/018680
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. diagnosed with endometriotic cyst by clinical examination and ultrsound
2. ovarian endometrioma <6cm
Exclusion Criteria
1.history of hormonal treatment in the past 3 mnoths
2.FSH >15 mIU/ml
3. pregnancy
4. post menopausal
5. prevoius ovarian surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in AMH levels after Dienogest therapy vs surgeryTimepoint: Change in AMH levels after Dienogest therapy vs surgery <br/ ><br>Dienogest group- 0,3,6 months <br/ ><br>Surgery group- Before surgery,2 weeks after surgery,3 months after surgery.
- Secondary Outcome Measures
Name Time Method 1. To study and compare the reduction in pain related symptoms within 3 mnoths <br/ ><br>2. To study and compare the effects of 3 months Dienogest therapy vs Endometriotic Cystectomy on Antral Follicle Count <br/ ><br>To assess and compare Spontaneous Conception rates after Dienogest Therapy vs surgery <br/ ><br>To assess the quanitative reduction in cyst size after Dienogest therapy vs surgeryTimepoint: 3 months